Akcea Therapeutics, Inc. Deferred Revenue
Akcea Therapeutics, Inc. had Deferred Revenue of $50.58 million as of 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-02-28
- 2017-12-31: Deferred Revenue, Current $50.58M.
- 2017-09-30: Deferred Revenue, Current $54.04M.
- 2017-06-30: Deferred Revenue, Current $54.16M.
- 2016-12-31: Deferred Revenue, Current $0.00.
| Period end | Deferred Revenue, Current |
|---|---|
| 2017-12-31 | $50.58M 10-K · filed 2018-02-28 |
| 2017-09-30 | $54.04M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $54.16M 10-Q · filed 2017-08-09 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-28 |